MHRA-100209-PIP01-21

Key Facts

Active Substance
Active Substance:
  • Peptide derivative of glucagon-like-peptide 1 and glucagon with fatty acid side chain
Invented Name
Not yet available
PIP Number MHRA-100209-PIP01-21
Pharmaceutical form(s)
Pharmaceutical form(s):
  • Solution for injection
Therapeutic area
Therapeutic area:
  • Gastroenterology-Hepatology
Conditions / Indications
Conditions / Indications:
  • Treatment of obesity
Route(s) of administration
Route(s) of administration:
  • Subcutaneous use
PIP applicant
Decision Type
Decision Type
P: decision agreeing on a paediatric investigation plan, with or without partial waiver(s) or deferrals(s)
Compliance Check
Compliance Check
No
Compliance Check Decision Date
Compliance Check Procedure Number

Decision Document

Decision Document Decision Document on a Paediatric Investigation Plan (PIP):Peptide derivative of glucagon-like-peptide 1 and glucagon with fatty acid side chain.pdf
Published Date 25/05/2023